BNP Paribas Financial Markets cut its position in American Vanguard Co. (NYSE:AVD – Free Report) by 18.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 96,382 shares of the basic materials company’s stock after selling 22,110 shares during the quarter. BNP Paribas Financial Markets owned about 0.33% of American Vanguard worth $446,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently modified their holdings of the company. Topline Capital Management LLC acquired a new position in American Vanguard in the 4th quarter valued at about $3,758,000. JPMorgan Chase & Co. grew its holdings in shares of American Vanguard by 26.0% during the fourth quarter. JPMorgan Chase & Co. now owns 376,626 shares of the basic materials company’s stock worth $1,744,000 after purchasing an additional 77,728 shares during the last quarter. Gamco Investors INC. ET AL bought a new position in American Vanguard during the 4th quarter worth approximately $278,000. Dynamic Technology Lab Private Ltd acquired a new stake in shares of American Vanguard during the fourth quarter worth $198,000. Finally, Oxford Asset Management LLP acquired a new position in shares of American Vanguard in the 4th quarter valued at about $163,000. 79.04% of the stock is owned by institutional investors.
American Vanguard Stock Down 1.9%
American Vanguard stock opened at $4.18 on Monday. The company has a market capitalization of $120.33 million, a PE ratio of -4.06 and a beta of 1.24. The firm’s fifty day moving average is $4.16 and its 200 day moving average is $4.90. The company has a quick ratio of 0.79, a current ratio of 1.89 and a debt-to-equity ratio of 0.55. American Vanguard Co. has a 12-month low of $3.28 and a 12-month high of $9.84.
About American Vanguard
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.
Read More
- Five stocks we like better than American Vanguard
- NYSE Stocks Give Investors a Variety of Quality Options
- This Market Sell-Off Might Trigger a Value Rotation Into Pepsi
- Are Penny Stocks a Good Fit for Your Portfolio?
- Alphabet Stock Lags—But Waymo May Be Its Hidden Driver
- Are Penny Stocks a Good Fit for Your Portfolio?
- Trade Desk Silences Critics; Recovery Looks Poised to Continue
Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.